MTOR and cancer: The demonstration that mTOR-targeting therapies could be effective cancer therapeutics through the modulation of cancer metabolism and epigenetics [137], and the future development of specific and accurate ways to inhibit mTORC2 activity represent promising strategies to target cancer metabolism and protein PTM networks.